Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joost Raaphorst

Showing results (61-70 of 89) with videos related to

Pageof 9
Sort By:
Journal of Autoimmunity|July 2, 2023
Does COVID-19 impact the prevalence of myositis specific antibodies in the Netherlands? A comparative nationwide studyRenske G Kamperman, Ester Mm van Leeuwen, Myrthe Willems, et al.
Rheumatology (Oxford, England)|May 10, 2022
Ultrasound and MR muscle imaging in new onset idiopathic inflammatory myopathies at diagnosis and after treatment: a comparative pilot studyAnne W Walter, Johan Lim, Joost Raaphorst, et al.
Frontiers in Immunology|January 25, 2024
TCRβ clones in muscle tissue share structural features in patients with idiopathic inflammatory myopathy and are associated with disease activityDornatien C Anang, Hannah A W Walter, Johan Lim, et al.
Journal of Neurology|September 28, 2016
The frontotemporal syndrome of ALS is associated with poor survivalRosanne Govaarts, Emma Beeldman, Mike J Kampelmacher, et al.
BMJ Open|July 10, 2023
Treatment with add-on IVIg in Myositis Early In the diSease course May be sUperior to Steroids alone for reaching CLinical improvEment (TIME IS MUSCLE): study protocol of a phase-2 double-blind placebo-controlled randomised trialRenske G Kamperman, Johannes A Bogaards, Sanne W Evers, et al.
Neuroimage. Clinical|February 26, 2022
Cortical and subcortical changes in resting-state neuronal activity and connectivity in early symptomatic ALS and advanced frontotemporal dementiaRosanne Govaarts, Emma Beeldman, Matteo Fraschini, et al.
Neurology|September 14, 2012
The ALS-FTD-Q: a new screening tool for behavioral disturbances in ALSJoost Raaphorst, Emma Beeldman, Ben Schmand, et al.
JAMA|December 12, 2018
Effect of Mexiletine on Muscle Stiffness in Patients With Nondystrophic Myotonia Evaluated Using Aggregated N-of-1 TrialsBas C Stunnenberg, Joost Raaphorst, Hans M Groenewoud, et al.
The Journal of Allergy and Clinical Immunology|November 6, 2022
Comprehensive overview of autoantibody isotype and subclass distributionMikhail Volkov, Mariateresa Coppola, Ruth Huizinga, et al.
Neurology|July 31, 2012
Hexanucleotide repeat expansions in C9ORF72 in the spectrum of motor neuron diseasesWouter van Rheenen, Marka van Blitterswijk, Mark H B Huisman, et al.
Pageof 9

Showing results (61-70 of 89) with videos related to

Sort By:
Pageof 9
Journal of Autoimmunity|July 2, 2023
Does COVID-19 impact the prevalence of myositis specific antibodies in the Netherlands? A comparative nationwide studyRenske G Kamperman, Ester Mm van Leeuwen, Myrthe Willems, et al.
Rheumatology (Oxford, England)|May 10, 2022
Ultrasound and MR muscle imaging in new onset idiopathic inflammatory myopathies at diagnosis and after treatment: a comparative pilot studyAnne W Walter, Johan Lim, Joost Raaphorst, et al.
Frontiers in Immunology|January 25, 2024
TCRβ clones in muscle tissue share structural features in patients with idiopathic inflammatory myopathy and are associated with disease activityDornatien C Anang, Hannah A W Walter, Johan Lim, et al.
Journal of Neurology|September 28, 2016
The frontotemporal syndrome of ALS is associated with poor survivalRosanne Govaarts, Emma Beeldman, Mike J Kampelmacher, et al.
BMJ Open|July 10, 2023
Treatment with add-on IVIg in Myositis Early In the diSease course May be sUperior to Steroids alone for reaching CLinical improvEment (TIME IS MUSCLE): study protocol of a phase-2 double-blind placebo-controlled randomised trialRenske G Kamperman, Johannes A Bogaards, Sanne W Evers, et al.
Neuroimage. Clinical|February 26, 2022
Cortical and subcortical changes in resting-state neuronal activity and connectivity in early symptomatic ALS and advanced frontotemporal dementiaRosanne Govaarts, Emma Beeldman, Matteo Fraschini, et al.
Neurology|September 14, 2012
The ALS-FTD-Q: a new screening tool for behavioral disturbances in ALSJoost Raaphorst, Emma Beeldman, Ben Schmand, et al.
JAMA|December 12, 2018
Effect of Mexiletine on Muscle Stiffness in Patients With Nondystrophic Myotonia Evaluated Using Aggregated N-of-1 TrialsBas C Stunnenberg, Joost Raaphorst, Hans M Groenewoud, et al.
The Journal of Allergy and Clinical Immunology|November 6, 2022
Comprehensive overview of autoantibody isotype and subclass distributionMikhail Volkov, Mariateresa Coppola, Ruth Huizinga, et al.
Neurology|July 31, 2012
Hexanucleotide repeat expansions in C9ORF72 in the spectrum of motor neuron diseasesWouter van Rheenen, Marka van Blitterswijk, Mark H B Huisman, et al.
Pageof 9